[Molecular target therapy for colonic neoplasms]
- PMID: 17370595
- DOI: 10.2169/naika.96.289
[Molecular target therapy for colonic neoplasms]
Similar articles
-
[New developments in immunotherapy for digestive system diseases].Nihon Naika Gakkai Zasshi. 2005 Sep 10;94(9):1901-7. doi: 10.2169/naika.94.1901. Nihon Naika Gakkai Zasshi. 2005. PMID: 16223155 Review. Japanese. No abstract available.
-
Biological agents versus chemotherapy in the treatment of colorectal cancer.Expert Opin Pharmacother. 2006 Jul;7(10):1251-71. doi: 10.1517/14656566.7.10.1251. Expert Opin Pharmacother. 2006. PMID: 16805714 Review.
-
Technology evaluation: bevacizumab, Genentech/Roche.Curr Opin Mol Ther. 2003 Dec;5(6):657-67. Curr Opin Mol Ther. 2003. PMID: 14755893
-
Accrual delayed in adjuvant bevacizumab trial.J Natl Cancer Inst. 2006 Apr 5;98(7):439-40. doi: 10.1093/jnci/djj148. J Natl Cancer Inst. 2006. PMID: 16595779 No abstract available.
-
Mixed news for Avastin.Nat Biotechnol. 2009 Jun;27(6):494. doi: 10.1038/nbt0609-494a. Nat Biotechnol. 2009. PMID: 19513035 No abstract available.